nice time to buy? longHello guys, it looks very interesting today REGENERON PHARMACEUTICALS INC. Everyone on the chart is waiting for questions if there are any comments. Good trade everyone by Harold-Finch0
REGN Long (Swing)It's moving closeer to a low trend and the MACD histogram is negative. Longby zyh617517224220
Start of long trade.Chart shows reversal has started. Might want to wait for confirmation. But I started a long trade (475-515). Long term position held for decade.Longby BiotechkingUpdated 0
$REGN - on the verge of break-outThe main thesis is that $REGN pattern is similar to $ABBV; though it needed a catalyst for reversal. Today's news is the one + earnings next week. Target 1: $575 - short-term (earnings as catalyst) Target 2: $615 - mid-term (post-earnings till next earnings) Target 3: $650 - mid-year Longby game_trader112
RSI Spike and Long Breakout StrategyThe last two long breakouts followed a spike in the RSI. The RSI spike this week. Maybe next week we will get the long breakout call.Longby Biotechking0
curling RSI + breakout past sma!dip entry when it dips under SMA support, just look at its history, also you can see at the top indicator how the rsi has bottom and is now curling back to the upside towards 70, great long here!! long 517, stop loss 455, price target 640!! goodluck to longs <3Longby Vibranium_Capital2217
REGN longChart Suggests that we see a backtest of the MAs after making a new high. Will watch closely how this behaves near the MAs. A 5 year long base gives this a huge potential when it is breaking out.Longby AlexWe19920
REGN Possible ReversalREGN broke through red 20EMA line. RSI entered bullish zone while MACD made a Bullish Cross with stochastic to back it up. Looking for price to continue to close above 20EMA and maybe even breakthrough the upper channel. Have not entered yet.Longby PennantTrading111
REGN wedge bounceREGN has had its ups and downs, but since SEP 2019, a trendline was formed on the chart which we are now meeting again. Each time it met this trendline, the stock was met with a hard bounce. After running up to highs in July, the stock has been in a steady downtrend, which accelerated to the downside to meet the larger trendline. This is a great spot for a low risk, high reward long with the target at 505.55 to keep this play conservative. Because this play is contingent on a bounce almost immediately, the stop will be extremely tight and be placed at the break of the lower blue trendline , which will likely be about the 481-482 range, but price action can dictate otherwise. Due to the virus, this company can come out with random news extremely fast, so make sure to keep watch after entering, even if news is not likely. Longby Sid24080
Model Buy Signal: 489.00stop: 465.00 This is the models second crack at a regn reversal Longby IngenuityTrading1
REGN a counter trade idea.IF we have ( or almost ready ) correction - we´ll see a fast move to $550 zone. A good chance for new ATH is here. A massiv violation of the Supp zone ( below $470 ) ist our SL. Trade carefully!Longby rondoinvest21Updated 110
$REGN - Reversal? like this 13ema mount here. Inv c&h measured move is $415 but looks like it might get cut short. Yellow zone incoming (514-527) . neckline at $542Longby orb_trades0
REGENERON time for longXBI is uptrend in SPX, REGN is about to bounce from down side of the channel in REGN/XBILongby solidBus76050Updated 0
REGN to SPX analisys After normalization of REGN (with SPX) we see following patterns 1) pretty narrow channel since 2012 2) growing channel since 2018 3) RSI goes below 30 every to years There many chances to have rebound on these levelsLongby solidBus76050Updated 1
Regeneron to XBI shows signs of reversal Regeneron show signs on bounce to XBI (biotech index), XBI is growing to SPX itselfLongby solidBus76050111
REGN due for a bounceREGN has been beaten down while the market is up. I think the bottom is near. Trendline is holding. Potentially starting wave 5 First PT: $550 SL: $470 Longby linsterr111
$REGN and $ABBV - very similar dynamicsThis seems to me more than just coincidence considering the profile of product pipelines and therapeutic areas both companies bet on. I was watching both for some time and placed a position to $ABBV before earnings @ major support level, which was broken and then turned. Major support @ 468 (50% monthly Fib level) Potential upside to 700 with test of ATH 664. Very good R/R of 1:7. Good fundamentals on top of above made $REGN a definitive buy for me as I was waiting a good price to enter. Discussion purpose only, not an advice. Longby game_trader333